Medical Training Voice Over

Submit Audition/Proposal on this Project
Rate this Project

Project Main Details

Medical Training Voice Over 
This project involves the development of training materials for sales representatives in the pharmaceutical industry. We are looking for a professional, steady, natural and warm voice that will clearly and concisely narrate eLearning medical material to a listener. Experience with medical terminology is encouraged for applicants. Applicants will be expected to edit and organize the audio before final submission. Script would be given to the voice talent in a clean word document organized by slide number. 
2014-10-10 13:08:55 GMT
2014-10-17 14:00:00 (GMT -05:00) Eastern Time (US & Canada) 
Yes (click here to learn more about Voice123's SmartCast)
3 direct invitation(s) have been sent by the voice seeker resulting in 0 audition(s) and/or proposal(s) so far.
Voice123 SmartCast is seeking 25 auditions and/or proposals for this project (approx.) Invitations sent by SmartCast have resulted in 8 audition(s) and/or proposal(s) so far.

Project Parameters

The Voice Actor should be located in:
Flexible Price - USD 100 to USD 300
Training, business presentations, sales, and web sites
English - USA and Canada
Young Adult Male
• Audio files must be delivered via email OR
• Audio files must be delivered via FTP/Dropbox/Google Drive/cloud
• Deliver edited and finished voice tracks
Not defined
This is a non-union project

Script Details

custom demo required 
The National Heart, Lung, and Blood Institute defines asthma as a common chronic disorder of the airways that is complex and characterized by variable and recurring symptoms, airflow obstruction, bronchial hyperresponsiveness, and an underlying inflammation.
Exacerbations of asthma are defined as acute or subacute episodes of progressively worsening shortness of breath, cough, wheezing, and chest tightness, or some combination of these symptoms. Exacerbations are characterized by decreases in expiratory airflow that can be documented and quantified by simple measurement of lung function.
As with clinical manifestations of asthma, these episodes vary widely among and within individuals over time.
Studies suggest that a complex interaction between host factors, particularly genetics, and environmental factors early in life during immune system development may lead to altered immune system response and the expression of asthma.
Patients with atopy are genetically predisposed to develop an IgE-mediated response to common environmental allergens. Atopy is the strongest predisposing factor for developing asthma.
More than half of the asthma cases in the US population age 6 to 59 years were attributable to atopy. Therefore, blocking or preventing the atopic component could reduce the prevalence of asthma in the US.
The chronic inflammation that underlies the pathophysiology of asthma is mediated by a variety of inflammatory cell types. Airway inflammation involves an interaction of many cell types and mediators within the airways.
Increased numbers of mast cells found in bronchial smooth muscle may be related to airway hyperresponsiveness.
Macrophages are activated by allergens through IgE receptors to release inflammatory mediators and cytokines that amplify the inflammatory response.
Most, not all, people with asthma have elevated numbers of eosinophils in their airways which release many inflammatory mediators, including cytokines. Increases in eosinophils can indicate greater asthma severity.
Pharmacologic therapy is used to prevent and control asthma symptoms, reduce the frequency and severity of asthma exacerbations, and reverse airflow obstruction. Asthma medications are categorized into 2 general classifications: quick-relief and long-term control medications. Quick-relief medications are taken to provide prompt reversal of acute airflow obstruction and relief of accompanying bronchoconstriction. Long-term control medications are taken daily on a long-term basis to help achieve and maintain control of persistent asthma. Patients who have persistent asthma require medication from both classifications.
The classes of asthma medications, including short-acting beta2-agonists (or SABAs), inhaled corticosteroids (or ICSs), inhaled corticosteroid/long-acting beta2-agonist (or ICS/LABA) combinations, leukotriene modifiers, and other treatments such as theophylline, oral corticosteroids, and omalizumab. 
Please note that you should only use the script or your recording of it for auditioning purposes. The script is property, unless otherwise specified, of the voice seeker and it is protected by international copyright laws.

Voice-Seeker Details

Sign in to display the company name (if applicable)


Voice123 Team Comments

Voice123 consultations with this voice seeker regarding this project and/or other projects by this voice seeker, via phone, chat, and/or email.

unchecked This project - phone.

unchecked Previous projects - phone.

unchecked This project - email or chat.

unchecked Previous projects - email or chat.

checked Corporate web site for this voice-seeker confirmed by Voice123

Note: Voice123 strives to establish the legitimacy of all projects posted. However, Voice123 subscribers and users are responsible for confirming information stated by prospective voice seekers, agents and/or clients. Voice123 subscribers and users assume all liability for use of any information found through Voice123, or any of its publications.

This page contains the most important details of this project. If you find the information on this project inaccurate or inappropriate, please let us know by contacting us.

Submit Audition/Proposal on this Project